Correlation Between Enanta Pharmaceuticals and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and ANI Pharmaceuticals, you can compare the effects of market volatilities on Enanta Pharmaceuticals and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and ANI Pharmaceuticals.
Diversification Opportunities for Enanta Pharmaceuticals and ANI Pharmaceuticals
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Enanta and ANI is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and ANI Pharmaceuticals
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the ANI Pharmaceuticals. In addition to that, Enanta Pharmaceuticals is 1.29 times more volatile than ANI Pharmaceuticals. It trades about -0.1 of its total potential returns per unit of risk. ANI Pharmaceuticals is currently generating about -0.03 per unit of volatility. If you would invest 6,736 in ANI Pharmaceuticals on September 3, 2024 and sell it today you would lose (1,013) from holding ANI Pharmaceuticals or give up 15.04% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Enanta Pharmaceuticals vs. ANI Pharmaceuticals
Performance |
Timeline |
Enanta Pharmaceuticals |
ANI Pharmaceuticals |
Enanta Pharmaceuticals and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enanta Pharmaceuticals and ANI Pharmaceuticals
The main advantage of trading using opposite Enanta Pharmaceuticals and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |